Susquehanna International Group
CEROW

Susquehanna International Group’s CERo Therapeutics Warrants CEROW Stock Holding History

Susquehanna International Group’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-98,468
Closed -$1.31K – 13829
2025
Q3 		$1.31K Buy
+98,468
New +$1.75K ﹤0.01% 12188
2025
Q2 		– Sell
-192,874
Closed -$2.8K – 13877
2025
Q1 		$2.8K Buy
+192,874
New +$2.72K ﹤0.01% 12293
2024
Q2 		– Sell
-13,945
Closed -$1.24K – 13405
2024
Q1 		$1.24K Buy
+13,945
New +$848 ﹤0.01% 12007

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Susquehanna International Group's CEROW Position: Q4 2025 in Review

Susquehanna International Group sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 98,468 shares — an estimated $1.31K sold.

Susquehanna International Group first reported a position in CEROW in Q1 2024 and held it in 3 quarters. The position peaked at $2.8K in Q1 2025. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Susquehanna International Group reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 98,468 CERo Therapeutics Warrants shares in Q4 2025, an estimated $1.31K.
  • Susquehanna International Group first reported a position in CERo Therapeutics Warrants in Q1 2024 and held it in 3 quarters.
  • Susquehanna International Group's CERo Therapeutics Warrants position peaked at $2.8K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.